CTI Spin-Off Aims To Put Follow-On Biologics In The Clinic Within Two Years
This article was originally published in The Pink Sheet Daily
Executive Summary
Amgen products eyed as initial candidates, exec tells “The Pink Sheet” DAILY.Register for our free email digests: